スマート生検装置の世界市場レポート 2025年

スマート生検装置市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で40億5,000万米ドルに成長します。予測期間の成長は、個別化医療の成長、画像診断モダリティの進歩、バイオマーカー解析のための生検の増加、新規参入企業の市場参入、データコネクティビティの強化に起因しています。予測期間の主な動向には、ロボット支援生検、AIによる生検支援、ワイヤレス生検ツールの開発、ポータブル・ハンドヘルド機器、リアルタイムガイダンスシステムなどがあります。

がん罹患率の増加が、今後のスマート生検装置市場の成長を牽引すると予測されています。がんは、異常な細胞が制御不能に増殖し、通常の境界を越えて他の臓器に転移したり、近隣の組織に侵入したりすることで、体内のほぼすべての臓器や組織に発生する可能性のある広範な疾患を包含します。がん患者数の増加により、正確で標的を絞った組織サンプルの需要が高まっています。この需要は、診断と治療計画をサポートする高度な分子、画像、精密機能を特徴とするスマート生検装置の開発と強化に拍車をかけています。例えば、2024年1月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2050年までに3,500万人以上のがん患者が新たに発生し、2022年に記録された推定2,000万人の患者数と970万人の死亡者数から77％増加すると予測しました。したがって、がん患者数の増加がスマート生検市場の成長を牽引しています。

低侵襲手技の採用は、スマート生検装置市場の成長に大きく寄与する見通しです。低侵襲手術は、身体の正常な構造への障害を最小限に抑えるように設計されており、スマート生検装置を使用することで組織サンプリングの精度と正確性を高めることができます。これらの装置には、リアルタイム超音波やMRIガイダンスなどの高度な画像技術が組み込まれていることが多く、ヘルスケア専門家がより小さな切開で特定の部位を生検の対象とすることができます。これにより、患者の外傷を軽減し、診断精度を高めることができます。例えば、2023年10月に経済協力開発機構が発表したデータによると、チェコ共和国での白内障手術件数は8.4％増加し、2021年の131,612件に対し、2022年には142,670件となった。したがって、低侵襲手術の採用が増加していることがスマート生検装置市場の牽引要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界スマート生検装置 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のスマート生検装置市場：成長率分析
• 世界のスマート生検装置市場の実績：規模と成長, 2019-2024
• 世界のスマート生検装置市場の予測：規模と成長, 2024-2029, 2034F
• 世界スマート生検装置総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のスマート生検装置市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 針式生検器具
• 処置トレイ
• ローカリゼーションワイヤー
• その他の製品
• 世界のスマート生検装置市場ガイダンステクニック、実績と予測, 2019-2024, 2024-2029F, 2034F
• 超音波ガイド下生検
• 定位ガイド下生検
• 磁気共鳴画像誘導生検
• その他の指導手法
• 世界のスマート生検装置市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳がん
• 皮膚がん
• 肝臓がん
• 前立腺がん
• その他の用途
• 世界のスマート生検装置市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 学術研究機関
• 診断および画像診断センター
• 世界のスマート生検装置市場、針ベースの生検器具の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• コア針生検装置
• 細針吸引（FNA）装置
• 真空補助生検装置
• 世界のスマート生検装置市場、処置トレイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 事前にパッケージ化された生検処置トレイ
• カスタマイズ可能な処置トレイ
• 世界のスマート生検装置市場、ローカリゼーションワイヤのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フックワイヤー位置特定装置
• レーダー位置特定装置
• 磁気位置特定装置
• 世界のスマート生検装置市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生検マーカー
• 生検画像システム
• 生検ガイダンスシステム

第7章 地域別・国別分析

• 世界のスマート生検装置市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のスマート生検装置市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• スマート生検装置市場：競合情勢
• スマート生検装置市場：企業プロファイル
  • Cardinal Health Inc Overview, Products and Services, Strategy and Financial Analysis
  • General Electric Company Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Toshiba Corporation
• Siemens Healthineers
• FUJIFILM Holdings Corporation
• Becton Dickinson and Company
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Olympus Corporation
• Intuitive Surgical Inc.
• Hologic Inc.
• Cook Medical Inc.
• CONMED Corporation
• Leica Biosystems
• Argon Medical Devices Inc.
• Esaote SpA
• SOMATEX Medical Technologies GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• スマート生検装置市場2029：新たな機会を提供する国
• スマート生検装置市場2029：新たな機会を提供するセグメント
• スマート生検装置市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Smart biopsy devices are intelligent instruments designed to enhance the precision and efficiency of tissue sampling during medical procedures, often incorporating features such as image guidance, real-time feedback, or robotic assistance. These devices aim to improve diagnostic capabilities and patient outcomes, particularly in the context of cancer diagnosis and drug delivery.

The primary products within the category of smart biopsy devices include needle-based biopsy instruments, procedure trays, localization wires, and others. Needle-based biopsy instruments are tools used to extract a sample of the body's cells for laboratory analysis, collecting tissue or liquid samples from various organs such as bones, muscles, liver, and lungs. These devices employ guidance techniques such as ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and others. Smart biopsy devices find applications in various areas, including breast cancer, skin cancer, liver cancer, prostate cancer, and more. The end users of these devices include hospitals, academic and research institutes, as well as diagnostic and imaging centers.

The smart biopsy devices research report is one of a series of new reports from The Business Research Company that provides smart biopsy devices market statistics, including the smart biopsy devices industry's global market size, regional shares, competitors with smart biopsy devices market share, detailed smart biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the smart biopsy devices industry. This smart biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart biopsy devices market size has grown strongly in recent years. It will grow from $2.85 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased cancer cases, demand for minimally invasive procedures, innovations in medical devices, improved diagnostic accuracy

The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to personalized medicine growth, advancements in imaging modalities, rise in biopsy for biomarker analysis, market entry of new players, enhanced data connectivity. Major trends in the forecast period include robot-assisted biopsies, ai-driven biopsy assistance, development of wireless biopsy tools, portable and handheld devices, real-time guidance systems.

The increasing incidence of cancer is anticipated to drive the growth of the smart biopsy devices market in the future. Cancer encompasses a wide range of diseases that can occur in nearly any organ or tissue in the body when abnormal cells grow uncontrollably, breach their usual boundaries, and either spread to other organs or invade nearby tissues. The rising number of cancer cases has led to a greater demand for precise and targeted tissue samples. This demand has spurred the development and enhancement of smart biopsy devices featuring advanced molecular, imaging, and precision capabilities to support diagnosis and treatment planning. For example, in January 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that there will be over 35 million new cancer cases by 2050, representing a 77% increase from the estimated 20 million cases and 9.7 million deaths recorded in 2022. Therefore, the rising number of cancer cases is driving the growth of the smart biopsy device market.

The adoption of minimally invasive procedures is poised to contribute significantly to the growth of the smart biopsy devices market. Minimally invasive procedures, designed to minimize disruption to the body's normal structures, benefit from the use of smart biopsy devices to enhance precision and accuracy in tissue sampling. These devices often incorporate advanced imaging technologies such as real-time ultrasound or MRI guidance, enabling healthcare professionals to target specific areas for biopsy through smaller incisions. This reduces patient trauma and enhances diagnostic accuracy. For instance, data from the Organization for Economic Co-operation and Development in October 2023 revealed an 8.4% increase in cataract surgical procedures in the Czech Republic, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Therefore, the growing adoption of minimally invasive procedures is a driving factor in the smart biopsy devices market.

Major companies in the smart biopsy device market are developing advanced products, such as breast biopsy markers, to enhance the accuracy and effectiveness of breast cancer diagnostics. These markers are specifically designed to accurately identify the location of a tissue sample collected during a biopsy, assisting in future treatments and ensuring that the appropriate area is monitored for potential malignancy. For example, in August 2022, Mammotome, a US-based medical device company, introduced the Mammotome DualCore Dual Stage Core Biopsy System. This minimally invasive breast biopsy device employs a dual-stage process to deliver precise, high-quality tissue samples and is frequently used with ultrasound guidance to ensure accurate, safe, and efficient breast cancer diagnosis. Additionally, this system can be paired with advanced breast biopsy markers, providing clinicians with a comprehensive and innovative solution for ultrasound-guided breast biopsies.

Major companies in the smart biopsy devices market are introducing new products, such as dual-stage core biopsy instruments, to gain a competitive advantage. Dual-stage core biopsy involves a two-step process, starting with the acquisition stage, where the biopsy instrument is guided to obtain a tissue sample, followed by the extraction stage to retrieve the obtained tissue for diagnostic analysis. For instance, Mammotome, a breast cancer care solutions company, launched the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. This advanced system offers three programmable firing modes and one-handed operation, providing clinicians with a versatile tool for accessing challenging lesions. The system's ergonomic design minimizes needle movements and vibrations, enhancing the overall patient experience.

In June 2023, Quest Diagnostics, a medical laboratories company, acquired Haystack Oncology for $450 million. This strategic acquisition enhances Quest Diagnostics' cancer diagnostics portfolio by incorporating Haystack's highly sensitive minimal-residual disease (MRD) testing technology based on circulating tumor DNA (ctDNA). The addition of Haystack's advanced testing capabilities allows Quest to offer improved early detection of solid tumor cancers through blood-based clinical lab services, starting in 2024. Haystack Oncology Inc. specializes in developing and utilizing advanced technologies for MRD testing in the field of cancer diagnostics.

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart biopsy devices market consists of revenues earned by entities by providing services such as collecting biopsy samples, real-time cancer tissue characterization, minimally invasive biopsy, and precise tissue targeting. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart biopsy devices market also includes sales of image-guided biopsy devices, core biopsy devices, bone biopsy needles and devices, and molecular biopsy devices which are used in providing collecting biopsy samples, real-time cancer tissue characterization services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Biopsy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart biopsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart biopsy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Needle-Based Biopsy Instruments; Procedure Trays; Localization Wires; Other Products
• 2) By Guidance Technique: Ultrasound-Guided Biopsy; Stereotactic-Guided Biopsy; Magnetic Resonance Imaging-Guided Biopsy; Other Guidance Techniques
• 3) By Application: Breast Cancer; Skin Cancer; Liver Cancer; Prostate Cancer; Other Applications
• 4) By End-User: Hospitals; Academic And Research Institutes; Diagnostic And Imaging Centers
• Subsegments:
• 1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices; Fine Needle Aspiration (FNA) Devices; Vacuum-Assisted Biopsy Devices
• 2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays; Customizable Procedure Trays
• 3) By Localization Wires: Hook Wire Localization Devices; Radar Localization Devices; Magnetic Localization Devices
• 4) By Other Products: Biopsy Markers; Biopsy Imaging Systems; Biopsy Guidance Systems
• Companies Mentioned: Cardinal Health Inc; General Electric Company; Medtronic Plc; Danaher Corporation; Canon Medical Systems Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Biopsy Devices Market Characteristics

3. Smart Biopsy Devices Market Trends And Strategies

4. Smart Biopsy Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Smart Biopsy Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Smart Biopsy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Smart Biopsy Devices Market Growth Rate Analysis
• 5.4. Global Smart Biopsy Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Smart Biopsy Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Smart Biopsy Devices Total Addressable Market (TAM)

6. Smart Biopsy Devices Market Segmentation

• 6.1. Global Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Needle-Based Biopsy Instruments
• Procedure Trays
• Localization Wires
• Other Products
• 6.2. Global Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound-Guided Biopsy
• Stereotactic-Guided Biopsy
• Magnetic Resonance Imaging-Guided Biopsy
• Other Guidance Techniques
• 6.3. Global Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Skin Cancer
• Liver Cancer
• Prostate Cancer
• Other Applications
• 6.4. Global Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Academic And Research Institutes
• Diagnostic And Imaging Centers
• 6.5. Global Smart Biopsy Devices Market, Sub-Segmentation Of Needle-Based Biopsy Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Core Needle Biopsy Devices
• Fine Needle Aspiration (FNA) Devices
• Vacuum-Assisted Biopsy Devices
• 6.6. Global Smart Biopsy Devices Market, Sub-Segmentation Of Procedure Trays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Packaged Biopsy Procedure Trays
• Customizable Procedure Trays
• 6.7. Global Smart Biopsy Devices Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hook Wire Localization Devices
• Radar Localization Devices
• Magnetic Localization Devices
• 6.8. Global Smart Biopsy Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopsy Markers
• Biopsy Imaging Systems
• Biopsy Guidance Systems

7. Smart Biopsy Devices Market Regional And Country Analysis

• 7.1. Global Smart Biopsy Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Smart Biopsy Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Biopsy Devices Market

• 8.1. Asia-Pacific Smart Biopsy Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Biopsy Devices Market

• 9.1. China Smart Biopsy Devices Market Overview
• 9.2. China Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Biopsy Devices Market

• 10.1. India Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Biopsy Devices Market

• 11.1. Japan Smart Biopsy Devices Market Overview
• 11.2. Japan Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Biopsy Devices Market

• 12.1. Australia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Biopsy Devices Market

• 13.1. Indonesia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Biopsy Devices Market

• 14.1. South Korea Smart Biopsy Devices Market Overview
• 14.2. South Korea Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Biopsy Devices Market

• 15.1. Western Europe Smart Biopsy Devices Market Overview
• 15.2. Western Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Biopsy Devices Market

• 16.1. UK Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Biopsy Devices Market

• 17.1. Germany Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Biopsy Devices Market

• 18.1. France Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Biopsy Devices Market

• 19.1. Italy Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Biopsy Devices Market

• 20.1. Spain Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Biopsy Devices Market

• 21.1. Eastern Europe Smart Biopsy Devices Market Overview
• 21.2. Eastern Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Biopsy Devices Market

• 22.1. Russia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Biopsy Devices Market

• 23.1. North America Smart Biopsy Devices Market Overview
• 23.2. North America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Biopsy Devices Market

• 24.1. USA Smart Biopsy Devices Market Overview
• 24.2. USA Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Biopsy Devices Market

• 25.1. Canada Smart Biopsy Devices Market Overview
• 25.2. Canada Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Biopsy Devices Market

• 26.1. South America Smart Biopsy Devices Market Overview
• 26.2. South America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Biopsy Devices Market

• 27.1. Brazil Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Biopsy Devices Market

• 28.1. Middle East Smart Biopsy Devices Market Overview
• 28.2. Middle East Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Biopsy Devices Market

• 29.1. Africa Smart Biopsy Devices Market Overview
• 29.2. Africa Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Biopsy Devices Market Competitive Landscape And Company Profiles

• 30.1. Smart Biopsy Devices Market Competitive Landscape
• 30.2. Smart Biopsy Devices Market Company Profiles
  • 30.2.1. Cardinal Health Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Smart Biopsy Devices Market Other Major And Innovative Companies

• 31.1. Toshiba Corporation
• 31.2. Siemens Healthineers
• 31.3. FUJIFILM Holdings Corporation
• 31.4. Becton Dickinson and Company
• 31.5. Boston Scientific Corporation
• 31.6. B. Braun Melsungen AG
• 31.7. Olympus Corporation
• 31.8. Intuitive Surgical Inc.
• 31.9. Hologic Inc.
• 31.10. Cook Medical Inc.
• 31.11. CONMED Corporation
• 31.12. Leica Biosystems
• 31.13. Argon Medical Devices Inc.
• 31.14. Esaote SpA
• 31.15. SOMATEX Medical Technologies GmbH

32. Global Smart Biopsy Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Biopsy Devices Market

34. Recent Developments In The Smart Biopsy Devices Market

35. Smart Biopsy Devices Market High Potential Countries, Segments and Strategies

• 35.1 Smart Biopsy Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Smart Biopsy Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Smart Biopsy Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer